Author:
Xia Qiang,Liu Chunxiao,He Shaozhong,Wang Bin
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Ma X, Xiao Z, Li X, Wang F, Zhang J, Zhou R, et al. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis. Tumor Biol. 2014. doi: 10.1007/s13277-014-1731-5 .
2. Okegawa T, Nutahara K, Higashihara E. Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy. BJU Int. 1999;84(1):112–7.
3. Okegawa T, Nutahara K, Higashihara E. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic. J Urol. 2008;180:1342–7.
4. Okegawa T, Nutahara K, Higashihara E. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol. 2009;181:1091–7.
5. Okegawa T, Nutahara K, Higashihara E. Original article: clinical investigation association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory. Int J Urol. 2010;17:466–75.